General Overview on Osteoporosis
Bone tissue should be broken down and rebuilt continuously, just like all of the cells in our body. This process takes place when osteoclasts help to dissolve old bone tissue, while osteoblasts stimulate new bone growth. Osteoporosis is a disease of bone loss: A metabolic disorder characterized by boen resorption exceeding bone deposition. The result is weakened bones that are easily fractured.
Osteoporosis means "bone that is porous" (osteo= bone and porosis= porous). Osteoporosis is a serious health problem. About 28 million people in the United States have the condition. It is responsible for about 1.5 million fractures (broken bones) each year. This disease affects both men and women; however, 80% of those affected are women. Bone loss can begin prior to menopause. This indicates that it is not an estrogen deficiency disease because it can begin when estrogen levels are still high.
The standard medical protocol for osteoporosis is to use estrogen (commonly synthesized from pregnant mare's urine), in spite of the fact that the most authoritative medical textbooks do not support it. Estrogen has a limiting effect on osteoclasts, therefore Estrogen Dominance delas the breakdown o bone tissue but does not support bone building (osteoblast function).
John R. Lee, M.D., author of the book, What Your Doctor May Not Tell You About Menopause studied the effect of progesterone on osteoporosis and concluded that progesterone helped build new bone by stimulating osteoblastic activity. (Read Article: Osteoporosis - Based on Research by Dr. John R. Lee)